HRP20130065T1 - Cjepivo protiv salmonele za perad - Google Patents
Cjepivo protiv salmonele za perad Download PDFInfo
- Publication number
- HRP20130065T1 HRP20130065T1 HRP20130065TT HRP20130065T HRP20130065T1 HR P20130065 T1 HRP20130065 T1 HR P20130065T1 HR P20130065T T HRP20130065T T HR P20130065TT HR P20130065 T HRP20130065 T HR P20130065T HR P20130065 T1 HRP20130065 T1 HR P20130065T1
- Authority
- HR
- Croatia
- Prior art keywords
- salmonella
- group
- vaccine
- bacterium
- inactivated
- Prior art date
Links
- 229940124842 Salmonella vaccine Drugs 0.000 title 1
- 244000144977 poultry Species 0.000 title 1
- 241000607142 Salmonella Species 0.000 claims 39
- 229960005486 vaccine Drugs 0.000 claims 21
- 241000894006 Bacteria Species 0.000 claims 16
- 230000002238 attenuated effect Effects 0.000 claims 9
- 241000271566 Aves Species 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 6
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 claims 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 4
- 239000003085 diluting agent Substances 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 2
- 241000592155 Salmonella enterica subsp. enterica serovar Agona Species 0.000 claims 2
- 241001355103 Salmonella enterica subsp. enterica serovar Braenderup Species 0.000 claims 2
- 241001355140 Salmonella enterica subsp. enterica serovar Brandenburg Species 0.000 claims 2
- 241000940095 Salmonella enterica subsp. enterica serovar Bredeney Species 0.000 claims 2
- 241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 claims 2
- 241000607132 Salmonella enterica subsp. enterica serovar Gallinarum Species 0.000 claims 2
- 241000607726 Salmonella enterica subsp. enterica serovar Heidelberg Species 0.000 claims 2
- 241001148137 Salmonella enterica subsp. enterica serovar Panama Species 0.000 claims 2
- 241000607683 Salmonella enterica subsp. enterica serovar Pullorum Species 0.000 claims 2
- 241000293246 Salmonella enterica subsp. enterica serovar Saintpaul Species 0.000 claims 2
- 230000005540 biological transmission Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 238000002649 immunization Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 230000000153 supplemental effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (14)
1. Sastav cjepiva, naznačen time, da se upotrebljava za unakrsnu imunizacijsku zaštitu ptica od bolesti uzrokovanih najmanje jednom heterolognom bakterijom Salmonella i/ili za prevenciju prenošenja najmanje jedne heterologne bakterije Salmonella kod životinjskog roda ptica, gdje se cjepivo formulira za primjenu prime-boost strategije, koja obuhvaća najmanje jedno prvo prime-davanje atenuiranog imunogenog sastava ili istog takvog cjepiva, koje sadrži farmaceutsko ili veterinarsko prihvatljiv(o) pomoćno sredstvo, razrjeđivač ili nosač i najmanje jednu atenuiranu bakteriju Salmonella skupine D, što se primjenjuje na pticu prije najmanje jednog dopunskog boost-davanja neaktiviranog imugenog sastava ili istog takvog cjepiva, koje sadrži farmaceutski ili veterinarski prihvatljiv(o) pomoćno sredstvo, razrjeđivač ili nosač i najmanje jednu neaktiviranu bakteriju Salmonella skupine B i najmanje jednu neaktiviranu bakteriju Salmonella skupine D, pri čemu se prvo prime-davanje i dopunsko boost-davanje primjenjuju odvojeno u razmaku od 2 do 18 tjedana.
2. Cjepivo prema zahtjevu 1, naznačeno time, da Salmonella skupine B obuhvaća Salmonella Typhimurium, Salmonella Braenderup, Salmonella Agona, Salmonella Bredeney, Salmonella Heidelberg, Salmonella Indiana, Salmonella Saint-Paul, Salmonella Brandenburg.
3. Cjepivo prema zahtjevu 2, naznačeno time, da najmanje jedna neaktivirana Salmonella od Salmonella skupine B je Salmonella Typhimurium.
4. Cjepivo prema bilo kojem od zahtjeva 1 do 3, naznačeno time, da Salmonella skupine D obuhvaća Salmonella Enteritidis, Salmonella Panama, Salmonella Dublin, Salmonella Gallinarum, Salmonella Pullorum.
5. Cjepivo prema zahtjevu 4, naznačeno time, da najmanje jedna atenuirana Salmonella ili najmanje jedna neaktivirana Salmonella od Salmonella skupine D je Salmonella Enteritidis.
6. Cjepivo prema zahtjevu 1, naznačeno time, da:
nadalje obuhvaća najmanje jednu primjenu bakterije Salmonella skupine D u vremenskom razmaku od otprilike 2 tjedna do otprilike 18 tjedana, koja slijedi
nakon davanja najmanje jedne neaktivirane bakterije Salmonella skupine B.
7. Garnitura cjepiva ili pribor za cijepljenje životinja iz roda ptica, naznačen(a) time, da obuhvaća najmanje dvije fijale i zapakirani umetak s uputama za primjenu, gdje najmanje dvije fijale sadrže atenuiranu bakteriju Salmonella i neaktiviranu bakteriju Salmonella, dok je garnitura ili pribor cjepiva operativno sastavljen(a) u svrhu izvođenja davanja cjepiva životinji iz roda ptica i ostvarenja sigurnog i zaštitnog imunološkog učinka protiv bakterije Salmonella, pri čemu prva fijala sadrži imunogeni sastav ili cjepivo od atenuirane bakterije Salmonella skupine D, a druga fijala sadrži imunogeni sastav ili cjepivo od neaktivirane bakterije Salmonella skupine B kao i od neaktivirane bakterije Salmonella skupine D.
8. Garnitura ili pribor cjepiva prema zahtjevu 7, naznačen(a) time, da najmanje dvije fijale sadrže imunogeni sastav ili cjepivo od atenuirane bakterije Salmonella skupine D za višestruko prime-davanje te imunogeni sastav ili cjepivo od neaktivirane bakterije Salmonella skupine B kao i neaktivirane bakterije Salmonella skupine D za višestruko boost-davanje.
9. Uporaba sastava cjepiva, naznačena time, da je za proizvodnju lijeka za unakrsnu imunizacijsku zaštitu ptica od bolesti uzrokovanih najmanje jednom heterolognom bakterijom Salmonella i/ili za prevenciju prenošenja najmanje jedne heterologne bakterije Salmonella kod životinjskog roda ptica, gdje se cjepivo formulira za primjenu prime-boost strategije, koja obuhvaća najmanje jedno prvo prime-davanje atenuiranog imunogenog sastava ili istog takvog cjepiva, koje sadrži farmaceutsko ili veterinarsko prihvatljiv(o) pomoćno sredstvo, razrjeđivač ili nosač i najmanje jednu atenuiranu bakteriju Salmonella skupine D, što se primjenjuje na pticu prije najmanje jednog dopunskog boost-davanja neaktiviranog imugenog sastava ili istog takvog cjepiva, koje sadrži farmaceutski ili veterinarski prihvatljiv(o) pomoćno sredstvo, razrjeđivač ili nosač i najmanje jednu neaktiviranu bakteriju Salmonella skupine B i najmanje jednu neaktiviranu bakteriju Salmonella skupine D, pri čemu se prvo prime-davanje i dopunsko boost-davanje primjenjuju odvojeno u razmaku od 2 do 18 tjedana.
10. Uporaba prema zahtjevu 9, naznačena time, da Salmonella skupine B obuhvaća Salmonella Typhimurium, Salmonella Braenderup, Salmonella Agona, Salmonella Bredeney, Salmonella Heidelberg, Salmonella Indiana, Salmonella Saint-Paul, Salmonella Brandenburg.
11. Uporaba prema zahtjevu 10, naznačena time, da najmanje jedna neaktivirana Salmonella od Salmonella skupine B je Salmonella Typhimurium.
12. Uporaba prema jednom od zahtjeva 9 do 11, naznačena time, da Salmonella skupine D obuhvaća Salmonella Enteritidis, Salmonella Panama, Salmonella Dublin, Salmonella Gallinarum, Salmonella Pullorum.
13. Uporaba prema zahtjevu 12, naznačena time, da najmanje jedna atenuirana Salmonella ili najmanje jedna neaktivirana Salmonella od Salmonella skupine D je Salmonella Enteritidis.
14. Uporaba prema zahtjevu 9, naznačena time, da:
nadalje obuhvaća najmanje jednu primjenu bakterije Salmonella skupine D u vremenskom razmaku od otprilike 2 tjedna do otprilike 18 tjedana, koja slijedi
nakon davanja najmanje jedne neaktivirane bakterije Salmonella skupine B.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86952406P | 2006-12-11 | 2006-12-11 | |
| PCT/US2007/086979 WO2008073891A2 (en) | 2006-12-11 | 2007-12-10 | Salmonella vaccine in poultry |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130065T1 true HRP20130065T1 (hr) | 2013-02-28 |
Family
ID=39281421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130065TT HRP20130065T1 (hr) | 2006-12-11 | 2013-01-25 | Cjepivo protiv salmonele za perad |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8062645B2 (hr) |
| EP (1) | EP2099479B1 (hr) |
| JP (1) | JP5229637B2 (hr) |
| CN (1) | CN101578108A (hr) |
| AU (1) | AU2007333169B2 (hr) |
| BR (1) | BRPI0720111B1 (hr) |
| CA (1) | CA2672026C (hr) |
| CO (1) | CO6190623A2 (hr) |
| DK (1) | DK2099479T3 (hr) |
| ES (1) | ES2398598T3 (hr) |
| HK (1) | HK1134783A1 (hr) |
| HR (1) | HRP20130065T1 (hr) |
| MX (1) | MX2009006178A (hr) |
| NZ (1) | NZ577610A (hr) |
| PL (1) | PL2099479T3 (hr) |
| PT (1) | PT2099479E (hr) |
| RU (2) | RU2455023C2 (hr) |
| SI (1) | SI2099479T1 (hr) |
| UA (1) | UA100370C2 (hr) |
| WO (1) | WO2008073891A2 (hr) |
| ZA (1) | ZA200904060B (hr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7449178B2 (en) * | 2002-04-05 | 2008-11-11 | Merial Limited | Attenuated gram negative bacteria |
| US7935355B2 (en) * | 2007-04-19 | 2011-05-03 | Nutritional Health Institute Laboratories, Llc | Composition and method for controlling intestinal pathogenic organisms |
| US20080260777A1 (en) * | 2007-04-19 | 2008-10-23 | Sotomayor Konky | Composition and method for controlling intestinal pathogenic organisms |
| FR2920295B1 (fr) * | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| WO2011019134A2 (ko) * | 2009-08-11 | 2011-02-17 | 전북대학교산학협력단 | 살모넬라 변이균주를 포함하는 가금티푸스 예방용 백신 조성물 |
| US9399057B2 (en) * | 2010-01-28 | 2016-07-26 | Universiteit Gent | Salmonella vaccine |
| WO2013034687A1 (en) | 2011-09-09 | 2013-03-14 | Universität Bern Verwaltungsdirektion | Avibacterium paragallinarum rtx toxin |
| EP2829281B1 (en) | 2012-03-22 | 2019-01-16 | KM Biologics Co., Ltd. | Lps vaccine |
| JP6196677B2 (ja) * | 2012-10-26 | 2017-09-13 | インターベット インターナショナル ベー． フェー． | 交差防御性サルモネラワクチン |
| MX368393B (es) * | 2012-12-07 | 2019-10-01 | Lohmann Animal Health Gmbh | Preparacion de vacunas vivas. |
| RU2683027C2 (ru) | 2012-12-20 | 2019-03-26 | Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. | Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию |
| CN103197078B (zh) * | 2013-03-28 | 2015-04-08 | 扬州大学 | 鸡白痢沙门菌分泌性蛋白SpiC的用途 |
| US20150359880A1 (en) * | 2014-06-16 | 2015-12-17 | Biomune Company | Dual adjuvant vaccine compositions, preparation and uses |
| CN105031635B (zh) * | 2015-04-03 | 2018-11-30 | 江苏省家禽科学研究所 | 一种鸡白痢沙门氏菌灭活疫苗的制备方法及其应用 |
| CN112649606A (zh) * | 2020-12-16 | 2021-04-13 | 江苏立华牧业股份有限公司 | 一种基于鸡白痢沙门氏菌x蛋白包被的抗体elisa检测方法 |
| KR102632608B1 (ko) * | 2021-03-11 | 2024-02-01 | 서울대학교산학협력단 | 약독화된 살모넬라 갈리나룸 생균 및 사균을 포함하는 가금티푸스 예방용 백신 조성물 |
| WO2022216731A1 (en) * | 2021-04-05 | 2022-10-13 | University Of Maryland, College Park | Salmonella vaccine |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US3919411A (en) | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
| GB9007194D0 (en) | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
| JPH07206705A (ja) | 1993-11-03 | 1995-08-08 | American Cyanamid Co | 生インオボ（ｉｎ ｏｖｏ）ワクチン |
| GB9615022D0 (en) | 1996-07-17 | 1996-09-04 | Mini Agriculture & Fisheries | Vaccine preparations |
| WO1999037759A2 (en) | 1998-01-22 | 1999-07-29 | Vrije Universiteit Brussel | Live attenuated salmonella vaccine |
| FR2775601B1 (fr) | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
| FR2776928B1 (fr) | 1998-04-03 | 2000-06-23 | Merial Sas | Vaccins adn adjuves |
| US6645740B1 (en) | 1999-06-10 | 2003-11-11 | Merial Limited | Nucleic acids encodings equine GM-CSF |
| MXPA02003108A (es) | 1999-09-25 | 2003-10-14 | Univ Iowa Res Found | Acidos nucleicos inmunoestimuladores. |
| AU5695701A (en) * | 2000-03-17 | 2001-10-03 | Upjohn Co | Salmonella vaccine materials and methods |
| US6605285B2 (en) * | 2000-03-29 | 2003-08-12 | G.B. Pant University Of Agriculture & Technology | Vaccine for protection of poultry against salmonellosis and a process for preparing the same |
| WO2004024027A2 (en) | 2002-06-07 | 2004-03-25 | University Of Florida | Endodontic files made using bulk metallic glasses |
| US6933957B2 (en) * | 2002-09-24 | 2005-08-23 | Ricoh Company, Ltd. | Pixel clock generation apparatus, pixel clock generation method, and image forming apparatus capable of correcting main scan dot position shift with a high degree of accuracy |
| RU2354399C2 (ru) | 2003-07-24 | 2009-05-10 | Мериал Лимитед | Вакцинная композиция и способ индуцирования иммунологического ответа у животного |
| US7582302B2 (en) | 2004-06-04 | 2009-09-01 | Merial Limited | Needle-free administration of FeLV vaccines |
-
2007
- 2007-10-12 UA UAA200907289A patent/UA100370C2/ru unknown
- 2007-12-10 NZ NZ577610A patent/NZ577610A/en active IP Right Revival
- 2007-12-10 SI SI200731135T patent/SI2099479T1/sl unknown
- 2007-12-10 BR BRPI0720111-7A patent/BRPI0720111B1/pt active IP Right Grant
- 2007-12-10 JP JP2009541504A patent/JP5229637B2/ja active Active
- 2007-12-10 CA CA2672026A patent/CA2672026C/en active Active
- 2007-12-10 RU RU2009126604/15A patent/RU2455023C2/ru not_active IP Right Cessation
- 2007-12-10 US US11/953,472 patent/US8062645B2/en active Active
- 2007-12-10 PT PT78654688T patent/PT2099479E/pt unknown
- 2007-12-10 EP EP07865468A patent/EP2099479B1/en active Active
- 2007-12-10 DK DK07865468.8T patent/DK2099479T3/da active
- 2007-12-10 PL PL07865468T patent/PL2099479T3/pl unknown
- 2007-12-10 ES ES07865468T patent/ES2398598T3/es active Active
- 2007-12-10 CN CNA2007800495661A patent/CN101578108A/zh active Pending
- 2007-12-10 MX MX2009006178A patent/MX2009006178A/es active IP Right Grant
- 2007-12-10 WO PCT/US2007/086979 patent/WO2008073891A2/en active Application Filing
- 2007-12-10 RU RU2009126604/15K patent/RU2596208C2/ru active
- 2007-12-10 AU AU2007333169A patent/AU2007333169B2/en active Active
-
2009
- 2009-06-10 ZA ZA200904060A patent/ZA200904060B/xx unknown
- 2009-07-10 CO CO09071883A patent/CO6190623A2/es not_active Application Discontinuation
-
2010
- 2010-03-03 HK HK10102274.1A patent/HK1134783A1/xx not_active IP Right Cessation
-
2013
- 2013-01-25 HR HRP20130065TT patent/HRP20130065T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0720111B1 (pt) | 2018-05-29 |
| PL2099479T3 (pl) | 2013-03-29 |
| PT2099479E (pt) | 2013-01-31 |
| NZ577610A (en) | 2011-08-26 |
| HK1134783A1 (en) | 2010-05-14 |
| CA2672026A1 (en) | 2008-06-19 |
| UA100370C2 (uk) | 2012-12-25 |
| EP2099479A2 (en) | 2009-09-16 |
| JP2010512412A (ja) | 2010-04-22 |
| RU2455023C2 (ru) | 2012-07-10 |
| AU2007333169B2 (en) | 2013-06-13 |
| MX2009006178A (es) | 2009-07-22 |
| EP2099479B1 (en) | 2012-11-07 |
| ES2398598T3 (es) | 2013-03-20 |
| DK2099479T3 (da) | 2013-01-14 |
| RU2009126604A (ru) | 2011-01-20 |
| RU2596208C2 (ru) | 2016-08-27 |
| CN101578108A (zh) | 2009-11-11 |
| SI2099479T1 (sl) | 2013-02-28 |
| ZA200904060B (en) | 2010-04-28 |
| AU2007333169A1 (en) | 2008-06-19 |
| WO2008073891A3 (en) | 2008-08-28 |
| WO2008073891A2 (en) | 2008-06-19 |
| JP5229637B2 (ja) | 2013-07-03 |
| CA2672026C (en) | 2016-02-02 |
| BRPI0720111A2 (pt) | 2014-01-14 |
| CO6190623A2 (es) | 2010-08-19 |
| US20080220022A1 (en) | 2008-09-11 |
| US8062645B2 (en) | 2011-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20130065T1 (hr) | Cjepivo protiv salmonele za perad | |
| BR112016006326A2 (pt) | formulação seca de uma vacina, uso de uma formulação seca, método para fabricação de uma formulação seca, e, vacina | |
| BRPI0918806A2 (pt) | composição compreendendo quitosana para administração ocular de vaninas em aves | |
| NO20073868L (no) | Levende attenuert rotavirus vaksine for oral administrering | |
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| BR112014026744A8 (pt) | anticorpo isolado ou fragmento de anticorpo, composição de anticorpo ou composição de fragmento de anticorpo, uso de modulação imune, uso de pelo menos uma composição de anticorpo ou fragmento de anticorpo, dispositivo médico, formulação, kit, artigo de fabricação para uso farmacêutico humano, método para produzir um anticorpo ou fragmento, animal ou planta transgênica, e, anticorpo ou porção ou variante especificada. | |
| HRP20201683T1 (hr) | Imunogeni pripravak namijenjen upotrebi u terapiji | |
| BR112017028212A2 (pt) | vacinação concomitante contra dengue e febre amarela | |
| CL2021002107A1 (es) | Triamtereno o nolatrexed para uso en el tratamiento de fenilcetonuria. | |
| WO2015051371A3 (en) | Haemophilus parasuis vaccine serovar type four | |
| CA2931139C (en) | Swine vaccine against prrs and lawsonia intracellularis | |
| RU2020109137A (ru) | Вакцина для защиты от streptococcus suis | |
| ES2753654T3 (es) | Composición que inhibe patógenos Gram negativos en Galloanserae | |
| RU2018145441A (ru) | Способ уменьшения заражения яиц | |
| ES2771473T3 (es) | Vacuna para proteger a un rumiante contra la neumonía causada por Mannheimia haemolytica | |
| JP6712760B2 (ja) | サルモネラワクチン | |
| WO2007135420A3 (en) | Defective interfering virus | |
| CL2013002829A1 (es) | Formulacion inmunogenica que contiene bcg vivas recombinantes que expresan antigenos de metapneumovirus (hmpv) en una suspension que se prepara a partir de un liofilizado sin la necesidad de adjuvante; su uso farmaceutico; vacuna contra hmpv. | |
| BR112021023292A2 (pt) | Composto, formulação, composição de vacina, composição farmacêutica, e, método para modular uma resposta imune em um indivíduo | |
| Markel | Science Diction: The Origin of the Word'Vaccine' | |
| US20220040289A1 (en) | Rabies Composition Comprising Pika Adjuvant | |
| Sambala | Vaccine effectiveness and coverage against the 2009 pandemic influenza in Ghana and Malawi | |
| UA129264U (uk) | Вакцина "сальмосан-1" полівалентна інактивована концентрована проти сальмонельозу тварин та птиці | |
| BR112017004703A2 (pt) | ?vacina e método para proteção de progênie de uma porca contra infeccção por um vírus de diarreia endêmica suína? | |
| AR042035A1 (es) | Uso de rmlt como antigeno marcador para vacunas y como un aditivo sinergico con amphigen |